Cargando…
Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose
The safety of a novel modified‐release oral capsule with orlistat and acarbose (MR‐OA) was investigated in 67 obese middle‐aged White men with a body mass index of 32 to 40 kg/m(2) or 30 to 32 kg/m(2) plus waist circumference >102 cm. The purpose of this investigation was to compare MR‐OA with th...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518499/ https://www.ncbi.nlm.nih.gov/pubmed/33580745 http://dx.doi.org/10.1002/cpdd.920 |